Ind-Swift Laboratories informs about outcome of board meeting

31 Jul 2021 Evaluate
Ind-Swift Laboratories has informed that the Board of Directors of the Company in its Meeting held on today July 30, 2021 considered and approved the following: Slump Sale of the Active Pharmaceuticals Ingredients (API) business of the Company on a going concern basis to PI Industries (Buyer), subject to receipt of requisite approvals including that of the Shareholder of the Company and in this regard a Business Transfer Agreement (BTA) between the Company and the Buyer has been executed; To Convene Extra-Ordinary General Meeting of the Company on 28 August, 2021 at 11.00 AM. The information required pursuant to Regulation 30 of the SEBI (LODR) Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 is enclosed as Annexure 1.

The above information is a part of company’s filings submitted to BSE.

Ind-Swift Lab. Share Price

118.60 -0.30 (-0.25%)
14-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.00
Dr. Reddys Lab 6080.25
Cipla 1565.50
Zydus Lifesciences 1110.95
Lupin 1601.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.